thisdrug what a medicine's name tells you

WHO naming stem · suffix · 20 listed names

-gliptin

dipeptidyl aminopeptidase–IV inhibitors

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -gliptin as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -gliptin. So the letters gliptin sit at the end of the name (…gliptin).

All 20 names WHO lists under -gliptin

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. alogliptin
  2. anagliptin
  3. bisegliptin
  4. carmegliptin
  5. cofrogliptin
  6. denagliptin
  7. dutogliptin
  8. evogliptin
  9. garvagliptin
  10. gemigliptin
  11. gosogliptin
  12. linagliptin
  13. melogliptin
  14. omarigliptin
  15. prusogliptin
  16. saxagliptin
  17. sitagliptin
  18. teneligliptin
  19. trelagliptin
  20. vildagliptin

Decode another name

Decoded

alogliptin

Listed INNCarries 2 WHO stems, most specific first: -gliptin …

  • -gliptinend of the nameWHO lists it hereWHO definition: dipeptidyl aminopeptidase–IV inhibitors
  • gliinside the nameWHO lists it hereWHO definition: antihyperglycaemics

“alogliptin” is an INN that WHO lists under -gliptin, gli in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -gliptin (Part II B) and the 20 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.